The World Health Organization listed AstraZeneca’s Covid-19 vaccine for emergency use, widening access in the developing world, while sources said the EU is in talks with Moderna on buying more vaccines.
Countries across the globe shut their borders to Britain on Dec. 21 due to fears about a highly infectious new coronavirus strain, causing travel chaos and raising the prospect of food shortages days before Britain is set to leave the European Union.
Global coronavirus cases rose by more than 500,000 for the first time, a record one-day increase as countries across the Northern Hemisphere reported daily spikes.
Global coronavirus cases exceeded 10 million on Sunday according to a Reuters tally, marking a major milestone in the spread of the respiratory disease that has so far killed almost half a million people in seven months.
The coronavirus pandemic is accelerating, with Thursday’s 150,000 new cases the highest in a single day and nearly half of those in the Americas, the World Health Organization (WHO) said.
U.S. President Donald Trump will seek $2.5 billion from Congress to fight the coronavirus epidemic, and U.S. and South Korean militaries are considering scaling back joint training as the virus spreads in Europe and the Middle East.
Takeda Pharmaceutical Co. trimmed the company’s full-year fiscal 2019 loss forecast on strong sales of core drugs and progress in consolidating with Shire Plc.
Human antibodies made in genetically engineered cows have proved safe in an early-stage clinical trial.
Laval, Quebec-based Valeant Pharmaceuticals International, Inc. (VRX) announced today that it will acquire Mercury (Cayman) Holdings, the holding company of Amoun Pharmaceutical, for about $800 million and contingent payments. Amoun Pharmaceutical is one of the leading drug makers in Egypt. It has a large manufacturing facility in El-Oubour City, a suburb near Cairo, and five […]